Research on the regrowth of cochlear cells may lead to medical treatments that restore hearing. Unlike birds and fish, humans and other mammals are generally incapable of regrowing the cells of the inner ear that convert sound into neural signals when those cells are damaged by age or disease. Researchers are making progress in
gene therapy and
stem-cell therapy that may allow the damaged cells to be regenerated. Because hair cells of
auditory and
vestibular systems in birds and fish have been found to regenerate, their ability has been studied at length. In addition,
lateral line hair cells, which have a
mechanotransduction function and are found in
anamniotes, have been shown to regrow in species such as the
zebrafish. Researchers have identified a mammalian gene that normally acts as a
molecular switch to block the regrowth of cochlear hair cells in adults. The Rb1 gene encodes the
retinoblastoma protein, which is a
tumor suppressor. Rb stops cells from dividing by encouraging their exit from the cell cycle. Not only do hair cells in a culture dish regenerate when the Rb1 gene is deleted, but mice bred to be missing the gene grow more hair cells than control mice that have the gene. Additionally, the
sonic hedgehog protein has been shown to block activity of the
retinoblastoma protein, thereby inducing cell cycle re-entry and the regrowth of new cells. Several
Notch signaling pathway inhibitors, including the
gamma secretase inhibitor LY3056480, are being studied for their potential ability to regenerate hair cells in the cochlea.
TBX2 (T-box transcription factor 2) has been shown to be a
master regulator in the differentiation of inner and outer hair cells. This discovery has allowed researchers to direct hair cells to develop into either inner or outer hair cells, which could help in replacing hair cells that have died and prevent or reverse hearing loss. The cell cycle inhibitor p27Kip1 (
CDKN1B) has also been found to encourage regrowth of cochlear hair cells in mice following genetic deletion or knock down with siRNA targeting p27.{{cite journal |journal=Mol Cell Neurosci |date=Dec 2009 |volume=42 |issue=4 |pages=391–398 == See also ==